The Clinical Significance of RMI2 in Hepatocellular Carcinoma

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Hepatocellular carcinoma (HCC), which is the most common type of primary liver cancer, often presents at advanced stage with a dismal prognosis. Novel tumor biomarkers are needed to aid in HCC early detection and prognostication. Methods: Immunohistochemical staining for RecQ-mediated genome instability protein 2 (RMI2) was performed in 330 surgically resected HCC specimens and 190 adjacent normal tissues. Univariate and multivariate regression analysis were applied to identify prognostic indicators of HCC outcomes. Patient's survival was assessed with the Kaplan–Meier method. Results: RMI2 in HCC tissue was significantly higher than that in adjacent normal tissues, and was positively correlated with HCC histological grade and stage (P

Cite

CITATION STYLE

APA

Zheng, B., Wang, H., Wang, J. X., Liu, Z. H., Zhang, P., & Zhang, D. (2021). The Clinical Significance of RMI2 in Hepatocellular Carcinoma. Technology in Cancer Research and Treatment, 20. https://doi.org/10.1177/15330338211045496

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free